Registry of children with peripheral neuroblastic tumours and linked biobank
Collects clinical, genetic and tissue information from patients with neuroblastic tumours.
Plain-language title generated from the registry record
Registry title: SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
Key facts
- Where
- Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen, and Zurich, SwitzerlandSee the 9 sites
Where in Switzerland
- Kantonsspital Aarau AGAarau, SwitzerlandTaking people
- Universitäts-Kinderspital beider Basel (UKBB)Basel, SwitzerlandTaking people
- Ospedale San GiovanniBellinzona, SwitzerlandTaking people
- Inselspital BernBern, SwitzerlandTaking people
- HUG Hôpitaux Universitaires GenèveGeneva, SwitzerlandTaking people
- CHUV (centre hospitalier universitaire vaudois)Lausanne, SwitzerlandTaking people
- Kinderspital Zentralschweiz, LuzernLucerne, SwitzerlandTaking people
- Ostschweizer KinderspitalSankt Gallen, SwitzerlandTaking people
- Universitäts-Kinderspital ZürichZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Curie
- Trial code
- NCT05192980
- Record updated
- 22 July 2025
- Original description
The SIOPEN BIOPORTAL is a prospective non-therapeutic multi-centre international study aimed at developing an international Registry linked to a Virtual Biobank for all the patients with peripheral neuroblastic tumor within countries of the SIOPEN network. The overall aim of this study is to provide a GDPR-compliant framework to collect basic clinical annotations, biological and genetic features and information about the location on biospecimens for all the patients with a peripheral neuroblastic tumor including neuroblastoma, ganglioneuroblastoma and ganglioneuroma in the SIOPEN network.Read full original descriptionShow less
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
The SIOPEN BIOPORTAL is a prospective non-therapeutic multi-centre international study aimed at developing an international Registry linked to a Virtual Biobank for all the patients with peripheral neuroblastic tumor within countries of the SIOPEN network. The overall aim of this study is to provide a GDPR-compliant framework to collect basic clinical annotations, biological and genetic features and information about the location on biospecimens for all the patients with a peripheral neuroblastic tumor including neuroblastoma, ganglioneuroblastoma and ganglioneuroma in the SIOPEN network.
This study will support data and sample management and intensify cross-borders data and sample sharing fostering translational and clinical research. The post-hoc hypothesis formulated based on the data generated in this study will be used as statistical basis for future precision medicine programs based on improved biological characterization, patient stratification and therapeutic management.
Inclusion: I-1. Patients with PNT: ganglioneuroma or ganglioneuroblastoma or neuroblastoma, I-2. At the time of initial diagnosis of neuroblastic tumour, or at relapse/progression if not yet registered I-3. Written patient informed consent, or parents or legal representative written informed consent and assent of the child, adolescent or young adult; Non-Inclusion Criteria:; R-1. (Adult) Patients with olfactory neuroblastoma R-2. Central nervous system (CNS) neuroblastoma (as per the WHO classification).